Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Modulation of microRNA processing by 5-lipoxygenase.
Uebbing S, Kreiß M, Scholl F, Häfner AK, Sürün D, Garscha U, Werz O, Basavarajappa D, Samuelsson B, Rådmark O, Suess B, Steinhilber D. Uebbing S, et al. FASEB J. 2021 Feb;35(2):e21193. doi: 10.1096/fj.202002108R. Epub 2020 Nov 17. FASEB J. 2021. PMID: 33205517
The miRNA biogenesis is tightly regulated to avoid dysfunction and consequent disease development. Here, we describe modulation of miRNA processing as a novel noncanonical function of the 5-lipoxygenase (5-LO) enzyme in monocytic cells. ...Our o …
The miRNA biogenesis is tightly regulated to avoid dysfunction and consequent disease development. Here, we describe modulation of mi …
Modulation of smoke-induced DNA and microRNA alterations in mouse lung by licofelone, a triple COX-1, COX-2 and 5-LOX inhibitor.
Izzotti A, Balansky R, Micale RT, Pulliero A, La Maestra S, De Flora S. Izzotti A, et al. Carcinogenesis. 2020 Mar 13;41(1):91-99. doi: 10.1093/carcin/bgz158. Carcinogenesis. 2020. PMID: 31562745 Free PMC article.
Among nonsteroidal anti-inflammatory drugs (NSAIDs), licofelone is a triple inhibitor of both cyclooxygenases (COX-1 and COX-2) and of 5-lipooxygenase (5-LOX) that has shown some encouraging results in cancer prevention models. ...Moreover, the drug counteracted dys …
Among nonsteroidal anti-inflammatory drugs (NSAIDs), licofelone is a triple inhibitor of both cyclooxygenases (COX-1 and COX-2) and of 5
Regulation of genes in the arachidonic acid metabolic pathway by RNA processing and RNA-mediated mechanisms.
Lutz CS, Cornett AL. Lutz CS, et al. Wiley Interdiscip Rev RNA. 2013 Sep-Oct;4(5):593-605. doi: 10.1002/wrna.1183. Wiley Interdiscip Rev RNA. 2013. PMID: 23956046 Review.
Cyclooxygenase (COX) enzymes work in one arm of the pathway to produce prostaglandins (PGs) and thromboxanes (TXs), while the actions of 5-lipoxygenase (ALOX5 or 5LO) and its associated protein (ALOX5AP or FLAP) work in the other arm of the metabolic pathway to prod …
Cyclooxygenase (COX) enzymes work in one arm of the pathway to produce prostaglandins (PGs) and thromboxanes (TXs), while the actions of …
Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA, Huang XM, Hwang AC, Sharma-Walia N. Chandrasekharan JA, et al. J Virol. 2016 Nov 28;90(24):11020-11031. doi: 10.1128/JVI.01491-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27681120 Free PMC article.
Treating de novo KSHV-infected endothelial cells with lipoxin and epilipoxin creates an anti-inflammatory environment by decreasing the levels of NF-kappaB, AKT, ERK1/2, COX-2, and 5-lipoxygenase. Lipoxin treatment on CRISPR/CAS9 technology-mediated ALX/FPR gene del …
Treating de novo KSHV-infected endothelial cells with lipoxin and epilipoxin creates an anti-inflammatory environment by decreasing the leve …